M, J., SH, P., H, K., Y, K., UJ, Y., J, H., . . . SY, R. (2026). A Phase Ib/II Study of Pemigatinib in Combination with Paclitaxel in Patients with Gastric Cancer with FGFs/FGFRs Alterations. Cancer research and treatment. https://doi.org/10.4143/crt.2025.1352
Chicago Style (17th ed.) CitationM, Jung, et al. "A Phase Ib/II Study of Pemigatinib in Combination with Paclitaxel in Patients with Gastric Cancer with FGFs/FGFRs Alterations." Cancer Research and Treatment 2026. https://doi.org/10.4143/crt.2025.1352.
MLA (9th ed.) CitationM, Jung, et al. "A Phase Ib/II Study of Pemigatinib in Combination with Paclitaxel in Patients with Gastric Cancer with FGFs/FGFRs Alterations." Cancer Research and Treatment, 2026, https://doi.org/10.4143/crt.2025.1352.
Warning: These citations may not always be 100% accurate.
